Seldar Pharma, Inc.

Quick facts

Phase 2 pipeline

• ASP7147 · Immunology
  ASP7147 is a small molecule inhibitor of the PI3K delta subunit.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Seldar Pharma, Inc. portfolio CI brief
• Seldar Pharma, Inc. pipeline updates RSS